BDH2P1

Across TCGA pan-cancer cohorts, BDH2P1 RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of BDH2P1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where BDH2P1 RNA is repressed in tumor relative to normal tissue. In most cancer types BDH2P1 is over-expressed in tumor, although a few such as KIRP and KIRC show the opposite, repressed pattern.

KIRP, KIRC, and LUSC are the cancer types where BDH2P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in BDH2P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	Female	II,III,IV	−0.972	<.001	11	view →
KIRC	All	All	−0.283	<.001	9	view →
LUSC	Male	II,III,IV	−0.198	<.001	5	view →
KICH	Female	All	−0.431	.001	4	view →
STAD	All	All	−0.303	.009	4	view →
BRCA	All	All	−0.104	.005	4	view →
LUAD	All	III,IV	−0.435	.018	3	view →
HNSC	All	All	−0.107	.021	3	view →
CHOL	All	II,III,IV	+0.135	.001	2	view →
PRAD	All	All	−0.129	<.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 10 strongest of 10 lineages.

BDH2P1–KIRP

Open the KIRP breakdown →